Rimactane Side Effects
>>>Help Community - Post Your Rimactane Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Rimactane Side Effects
Rimactane Safety Reports reported to FDA
Total Rimactane reports: 14.Rimactane FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 8.
Take Rimactane Side Effects Survey or Share Your Rimactane Story.
Reported Rimactane Side Effects: blood glucose decreased, renal failure acute, nephrotic syndrome, fatigue, discomfort, cyanosis, blood bilirubin abnormal, blood alkaline phosphatase decreased, abdominal pain upper, nephritis interstitial, hepatitis fulminant.
More About Rimactane.
If you have questions about Rimactane, you can ask a Health Expert or Ask Patient Community about Rimactane.
Rimactane Side Effects Report #5246240-3
Pharmacist from JAPAN reported RIMACTANE problem on Feb 08, 2007. Male patient, 80 years of age, was diagnosed with tuberculosis and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: dysuria, haematuria, urine analysis abnormal. RIMACTANE dosage: 450 MG, ORAL. During the same period patient was treated with ETHAMBUTOL, ISONIAZID, DEPAS, ROHYPNOL, ENSURE, AVISHOT, LANIRAPID. Patient recovered.
Rimactane Side Effects Report #5259057-0
RIMACTANE problem was reported by a Physician from JAPAN on Feb 21, 2007. Female patient, 75 years of age, weighting 72.75 lb, was diagnosed with mycobacterial infection and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood pressure decreased, cardio-respiratory arrest, condition aggravated, disseminated intravascular coagulation, haemolytic anaemia, hepatitis fulminant, loss of consciousness, melaena. RIMACTANE dosage: 450 MG, ORAL. During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE, CLARITHROMYCIN, MUCODYNE, GLORIAMIN, PURSENNID, KAMAG G, JUZENTAIHOTO, UNASYN. Patient was hospitalized. Patient died on 10/09/2006.
Rimactane Side Effects Report #5352274-0
Consumer or non-health professional from JAPAN reported RIMACTANE problem on June 06, 2007. Male patient, 58 years of age, was diagnosed with pulmonary tuberculosis and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: herpes zoster disseminated, immune reconstitution syndrome. RIMACTANE dosage: unknown. During the same period patient was treated with PYRAMIDE, ISCOTIN, STREPTOMYCIN, ETHAMBUTOL HYDROCHLORIDE. Patient recovered.
Rimactane Side Effects Report #5050825-7
RIMACTANE problem was reported by a Physician from JAPAN on June 27, 2006. Male patient, 66 years of age, was diagnosed with pulmonary tuberculosis and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: haemodialysis, hepatic failure, hepatitis fulminant, somnolence, white blood cell count decreased. RIMACTANE dosage: 300 MG, ORAL. During the same period patient was treated with ISONIAZID, PYRAZINAMIDE, ETHAMBUTOL, ADEROXAL. Patient died on 05/21/2006.
Rimactane Side Effects Report #5067241-4
Health Professional from JAPAN reported RIMACTANE problem on July 12, 2006. Male patient, 72 years of age, was diagnosed with tuberculous pleurisy and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood creatinine increased, blood urea increased, hypoalbuminaemia, nephritis interstitial, nephrotic syndrome, proteinuria, renal failure acute. RIMACTANE dosage: unknown. During the same period patient was treated with ISONIAZID, ETHAMBUTOL, PYRAZINAMIDE. Patient was hospitalized. Patient recovered.
Rimactane Side Effects Report #5067242-6
RIMACTANE problem was reported by a Health Professional from JAPAN on July 12, 2006. Male patient, 72 years of age, was diagnosed with tuberculous pleurisy and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: nephritis interstitial, nephrotic syndrome, renal failure acute. RIMACTANE dosage: unknown. During the same period patient was treated with ISONIAZID, ETHAMBUTOL, PYRAZINAMIDE. Patient was hospitalized. Patient recovered.
Rimactane Side Effects Report #5081612-1
Consumer or non-health professional from BRAZIL reported RIMACTANE problem on July 31, 2006. Female patient, 37 years of age, weighting 138.9 lb, was diagnosed with morphoea and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood alkaline phosphatase decreased, blood bilirubin abnormal, blood glucose decreased, cyanosis, discomfort, fatigue, haematocrit increased. RIMACTANE dosage: unknown. During the same period patient was treated with DAPSONE. Patient recovered.
Rimactane Side Effects Report #5115350-3
RIMACTANE problem was reported by a Health Professional from JAPAN on Sept 13, 2006. Male patient, 72 years of age, was diagnosed with tuberculous pleurisy and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: hypoalbuminaemia, nephritis interstitial, nephrotic syndrome, proteinuria, renal failure acute. RIMACTANE dosage: unknown. During the same period patient was treated with ISONIAZID, ETHAMBUTOL HYDROCHLORIDE, PYRAZINAMIDE. Patient was hospitalized. Patient recovered.
Rimactane Side Effects Report #5120497-1
Health Professional from JAPAN reported RIMACTANE problem on Sept 21, 2006. Male patient, 72 years of age, was diagnosed with tuberculous pleurisy and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, glomerulonephritis minimal lesion, headache, nephrotic syndrome, renal failure acute, tubulointerstitial nephritis. RIMACTANE dosage: unknown. During the same period patient was treated with PYRAZINAMIDE, ETHAMBUTOL, ISONIAZID. Patient was hospitalized. Patient recovered.
Rimactane Side Effects Report #5127676-8
RIMACTANE problem was reported by a Consumer or non-health professional from BRAZIL on July 31, 2006. Female patient, 37 years of age, weighting 138.9 lb, was diagnosed with leprosy and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood alkaline phosphatase decreased, blood bilirubin abnormal, blood glucose decreased, blood sodium decreased, cyanosis, discomfort, fatigue. RIMACTANE dosage: unknown. During the same period patient was treated with DAPSONE, CLOFAZIMINE. Patient recovered.
Rimactane Side Effects Report #5132673-2
Consumer or non-health professional from BRAZIL reported RIMACTANE problem on Oct 05, 2006. Female patient, 37 years of age, weighting 138.9 lb, was diagnosed with leprosy and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood alkaline phosphatase decreased, blood bilirubin abnormal, blood glucose decreased, blood sodium decreased, cyanosis, discomfort, fatigue. RIMACTANE dosage: unknown. During the same period patient was treated with DAPSONE, CLOFAZIMINE. Patient recovered.
Rimactane Side Effects Report #5141104-8
RIMACTANE problem was reported by a Physician from JAPAN on Oct 19, 2006. Female patient was diagnosed with mycobacterial infection and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, haemolytic anaemia, hepatitis fulminant. RIMACTANE dosage: 450 MG, ORAL. Patient was hospitalized. Patient died.
Rimactane Side Effects Report #5148158-3
Physician from JAPAN reported RIMACTANE problem on Oct 26, 2006. Female patient, 75 years of age, weighting 72.75 lb, was diagnosed with mycobacterial infection and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: acid fast bacilli infection, angina unstable, blood glucose decreased, blood pressure decreased, cardio-respiratory arrest, condition aggravated, continuous haemodiafiltration, disseminated intravascular coagulation, dyspnoea. RIMACTANE dosage: 450 MG, ORAL. During the same period patient was treated with ETHAMBUTOL, CLARITHROMYCIN, MUCODYNE, GLORIAMIN, PURSENNID, KAMAG G, JUZENTAIHOTO, UNASYN. Patient was hospitalized. Patient died on 10/09/2006.
Rimactane Side Effects Report #5154225-0
RIMACTANE problem was reported by a Pharmacist from JAPAN on Oct 30, 2006. Male patient was diagnosed with tuberculosis and was treated with RIMACTANE. After drug was administered, patient experienced the following problems/side effects: urinary retention. RIMACTANE dosage: unknown. Patient was hospitalized. Patient recovered.